Back
Viking Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
VKTX
Viking Therapeutics, Inc.
Last Price:
$35.65
Seasonality Move:
17.52%
7 Day Trial
ALL ACCESS PASS
$
7
Viking Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Viking Therapeutics, Inc. has on average historically fallen by 12.3% based on the past 10 years of stock performance.
-
Viking Therapeutics, Inc. has fallen lower in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
-
Is Viking Therapeutics, Inc. Stock Undervalued?The current Viking Therapeutics, Inc. [VKTX] share price is $35.63. The Score for VKTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Viking Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Viking Therapeutics, Inc. has on average historically fallen by 12.3% based on the past 10 years of stock performance.
Viking Therapeutics, Inc. Stock Rating
Sell
47
Viking Therapeutics, Inc. (VKTX)
is a Sell
Is Viking Therapeutics, Inc. overpriced?
-
Viking Therapeutics, Inc. has fallen lower in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
Viking Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com
52-Week Data
52-Week High:
43.15
52-Week Low:
18.92
Prediction Charts
Market Cap:
4.1B
Price in USD:
35.63
Volume:
2.8M
Beta:
1.32
Technical Analysis
SMA50:
31.95
SMA100:
34.10
SMA200:
31.81
52-Wk Change:
19.85%
Stock Predictions
-
Is Viking Therapeutics, Inc. stock public?Yes, Viking Therapeutics, Inc. is a publicly traded company.
-
What is the Viking Therapeutics, Inc. stock quote today?The Viking Therapeutics, Inc. stock price is 35.63 USD today.
-
How to buy Viking Therapeutics, Inc. stock online?You can buy Viking Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-24 | 33.65 | 33.75 | 34.56 | 33.25 |
| Feb-25 | 33.44 | 33.12 | 34.38 | 33.08 |
| Feb-26 | 33.10 | 32.97 | 33.23 | 31.62 |
| Feb-27 | 32.16 | 33.84 | 33.91 | 32.13 |
| Mar-2 | 33.00 | 33.34 | 33.96 | 32.97 |
| Mar-3 | 32.81 | 31.93 | 33.00 | 31.39 |
| Mar-4 | 32.12 | 32.14 | 32.63 | 31.66 |
| Mar-5 | 31.75 | 31.51 | 32.16 | 30.19 |
| Mar-6 | 30.89 | 32.98 | 33.20 | 30.46 |
| Mar-9 | 32.87 | 33.61 | 33.80 | 32.51 |
| Mar-10 | 33.50 | 34.66 | 35.39 | 33.50 |
| Mar-11 | 34.80 | 35.76 | 35.80 | 33.91 |
| Mar-12 | 35.90 | 35.47 | 36.21 | 34.57 |
| Mar-13 | 35.95 | 35.63 | 37.50 | 35.25 |
Viking Therapeutics, Inc. Earnings
Viking Therapeutics, Inc. Earnings Report: Per Share Viking Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viking Therapeutics, Inc. Forecast Revenue Growth
Viking Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.39 per share, an increase next quarter of $0.09 per share, a decrease this year of $1.50 per share, and a decrease next year of $0.46 per share.
* Viking Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.